Answers are grounded in this paper and cite their sources.
These findings provide estimates of cancer risk based on BRCA1 and BRCA2 mutation carrier status using prospective data collection and demonstrate the potential importance of family history and mutation location in risk assessment.
No takes yet. Share an insight, caveat, or question.
Kuchenbaecker et al. (2017) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: